Frédéric F.
- Country
- Belgium
- Department
- Gastro-enterology
Research Overview
- Efficacy and Safety of RO7790121 in Induction and Maintenance Therapy for Moderately to Severely Active Crohn's Disease: A Phase III Multicenter Double-Blind Study
- A randomized, double-blind, placebo-controlled, multicenter phase III study to evaluate the efficacy and safety of ABX464 once daily for induction treatment in subjects with moderately to severely active ulcerative colitis
Data & Insights
Has run more than one trial at 24 of 195 partner sites.
Specializations
Inflammatory Bowel Disease Research
This investigator specializes in the therapeutic management of ulcerative colitis, with particular emphasis on treating patients with moderate to severe disease activity.
- Inflammatory Bowel Disease Management
- Novel Therapeutic Approaches
- Disease Activity Assessment
The research focus includes evaluating innovative treatments for achieving endoscopic improvement and symptomatic remission in ulcerative colitis patients.
Clinical Outcomes Research
The investigator conducts extensive research in long-term disease management and treatment effectiveness in inflammatory bowel conditions.
- Treatment Efficacy Assessment
- Safety Monitoring
- Extended Therapeutic Evaluation
Their work encompasses both short-term therapeutic responses and extended maintenance treatment outcomes.
Therapeutic Development
Research activities focus on innovative treatment protocols for inflammatory bowel conditions, including the evaluation of novel therapeutic agents.
- Treatment Protocol Development
- Therapeutic Response Assessment
- Clinical Efficacy Evaluation
The investigator evaluates various dosing strategies and their impact on disease management outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.